Management of PD-1/PD-L1 blockade immune-related skin toxicities: perspectives and issues

Martina Ferranti; Giulia Tadiotto Cicogna; Francesco Messina; Mauro Alaibac

doi:10.2217/imt-2021-0071

Management of PD-1/PD-L1 blockade immune-related skin toxicities: perspectives and issues

Immunotherapy. 2021 Jul;13(10):795-798. doi: 10.2217/imt-2021-0071. Epub 2021 May 6.

Authors

Martina Ferranti¹, Giulia Tadiotto Cicogna¹, Francesco Messina¹, Mauro Alaibac¹

Affiliation

¹ Department of Medicine-DIMED, Unit of Dermatology, University of Padova, Padova, Italy.

PMID: 33955235
DOI: 10.2217/imt-2021-0071

No abstract available

Keywords: anti-PD1 inhibitors; anti-PDL1 inhibitors; immune-checkpoint inhibitors; immune-related adverse events; immunotherapy; rechallenge; skin toxicities.

Publication types

Editorial

MeSH terms

Humans
Immune Checkpoint Inhibitors / adverse effects*
Immunotherapy / adverse effects*
Immunotherapy / methods*
Skin Diseases / etiology*
Skin Diseases / immunology*

Substances

Immune Checkpoint Inhibitors